{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:54:00Z","timestamp":1770843240029,"version":"3.50.1"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institute of Health Research (NIHR) Research Professorship and Cambridge Biomedical Research Centre"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.critrevonc.2020.102967","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T03:11:38Z","timestamp":1587525098000},"page":"102967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The 2018 assisi think tank meeting on breast cancer: International expert panel white paper"],"prefix":"10.1016","volume":"151","author":[{"given":"Meritxell","family":"Arenas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur","family":"Selek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orit","family":"Kaidar-Person","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Perrucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-0493","authenticated-orcid":false,"given":"Angel","family":"Montero Luis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Coles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitte","family":"Offersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1861-2895","authenticated-orcid":false,"given":"Icro","family":"Meattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"B\u00f6l\u00fckba\u015f\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6529-8328","authenticated-orcid":false,"given":"Maria Cristina","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8319-6429","authenticated-orcid":false,"given":"Bruno","family":"Cutuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Vidali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-0687","authenticated-orcid":false,"given":"Pierfrancesco","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilis","family":"Kouloulias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Masiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Bourgier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Ciabattoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Lancellotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lurdes","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-2293","authenticated-orcid":false,"given":"Philip","family":"Poortmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9749-649X","authenticated-orcid":false,"given":"Cynthia","family":"Aristei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2020.102967_bib0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijrobp.2013.06.2056","article-title":"Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ","volume":"87","author":"Abbott","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jso.23933","article-title":"The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: a prospective clinical utility assessment of the 12-gene DCIS scoreTM result","volume":"111","author":"Alvarado","year":"2015","journal-title":"J. Surg. Oncol."},{"issue":"9 Suppl","key":"10.1016\/j.critrevonc.2020.102967_bib0015","article-title":"NSABP B-43 is unlikely to produce a cost-effective treatment strategy for HER2+ DCIS","volume":"75","author":"Alvarado","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-016-3998-2","article-title":"The 2016 assisi think tank meeting on breast cancer: white paper","volume":"160","author":"Aristei","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejso.2018.01.010","article-title":"The assisi think tank meeting and survey of post MAstectomy radiation therapy after breast reconstruction: the ATTM-SMART report","volume":"44","author":"Aristei","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0030","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2007.11.4991","article-title":"Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial","volume":"25","author":"Bartelink","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semradonc.2015.08.001","article-title":"The role of post-mastectomy radiation therapy in patients with breast cancer responding to neoadjuvant chemotherapy","volume":"26","author":"Bazan","year":"2016","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0040","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","article-title":"The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from national surgical adjuvant breast and bowel project protocol B-27","volume":"21","author":"Bear","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0045","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2012.44.3358","article-title":"Should response to preoperative chemotherapy affect radiotherapy recommendations after mastectomy for stage II breast cancer?","volume":"30","author":"Bellon","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.amjsurg.2006.06.013","article-title":"Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study","volume":"192","author":"Benitez","year":"2006","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.critrevonc.2014.10.011","article-title":"Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer patients: a review","volume":"93","author":"Bernier","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clon.2017.12.022","article-title":"Can interrogation of tumour characteristics lead us to safely omit adjuvant radiotherapy in patients with early breast cancer?","volume":"30","author":"Bhattacharya","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.radonc.2018.07.005","article-title":"Post-mastectomy radiation therapy with or without implant-based reconstruction is safe in terms of clinical target volume coverage and survival - A matched cohort study","volume":"131","author":"Bj\u00f6hle","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0070","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.ejca.2013.02.031","article-title":"Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial","volume":"49","author":"Blamey","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"Suppl.1","key":"10.1016\/j.critrevonc.2020.102967_bib0075","doi-asserted-by":"crossref","first-page":"S311","DOI":"10.1016\/S0167-8140(19)31014-X","article-title":"Acute toxicity results after breast-conserving therapy in \u201cboost vs non boost (BONBIS)\u201d DCIS trial","volume":"133","author":"Bourgier","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","article-title":"Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial","volume":"120","author":"Brunt","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"102","key":"10.1016\/j.critrevonc.2020.102967_bib0085","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ijrobp.2018.08.049","article-title":"FAST phase III RCT of radiotherapy hypofractionation for treatment of early breast cancer: 10-year results (CRUKE\/04\/015)","volume":"2018","author":"Brunt","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0090","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","author":"Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.2002.20.1.17","article-title":"Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation","volume":"20","author":"Buchholz","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0100","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0360-3016(02)02850-X","article-title":"Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy","volume":"53","author":"Buchholz","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0105","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","article-title":"Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019","volume":"30","author":"Burstein","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijrobp.2019.07.052","article-title":"Lumpectomy plus hormone or radiation therapy alone for women aged 70 years or older with hormone receptor-positive early stage breast cancer in the modern era: an analysis of the national cancer database","volume":"105","author":"Buszek","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0115","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.clon.2017.06.003","article-title":"Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice","volume":"29","author":"Cain","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0120","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/cncr.30675","article-title":"The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer","volume":"123","author":"Cassidy","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0125","article-title":"Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ?","author":"Chadha","year":"2012","journal-title":"Int. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0130","first-page":"657","article-title":"Postmastectomy radiotherapy after neoadjuvant chemotherapy: a review of the evidence","volume":"29","author":"Chapman","year":"2015","journal-title":"Oncology (Williston Park)."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0135","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ijrobp.2012.07.2377","article-title":"Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ","volume":"85","author":"Childs","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0140","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.ijrobp.2011.11.025","article-title":"Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy","volume":"83","author":"Ciervide","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0145","series-title":"Radiotherapy Dose Fractionation","author":"Clinical Oncology, The Royal College of Radiologists","year":"2019"},{"issue":"15","key":"10.1016\/j.critrevonc.2020.102967_bib0150","first-page":"TPS666","article-title":"NSABP B-43: a phase III clinical trial to compare trastuzumab (T) given concurrently with radiation therapy (RT) to RT alone for women with HER2+ DCIS resected by lumpectomy (Lx)","volume":"31","author":"Cobleigh","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0155","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet."},{"issue":"10215","key":"10.1016\/j.critrevonc.2020.102967_bib0160","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(19)32959-9","article-title":"Accelerated partial breast irradiation: more questions than answers?","volume":"394","author":"Coles","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0170","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0175","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.canrad.2016.04.004","article-title":"Breast-conserving treatment for ductal carcinoma in situ: impact of boost and tamoxifen on local recurrences","volume":"20","author":"Cutuli","year":"2016","journal-title":"Cancer Radiother."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0180","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/j.clbc.2019.08.002","article-title":"Ductal carcinoma in situ (DCIS): a French National Survey. Analysis of 2,125 patients","volume":"20","author":"Cutuli","year":"2020","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0190","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial","volume":"31","author":"Donker","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"41","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2010","journal-title":"J Natl Cancer Inst Monogr."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0200","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0205","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0210","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijrobp.2012.01.068","article-title":"Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer","volume":"83","author":"Fowble","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0215","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12032-018-1121-8","article-title":"De-escalation of breast radiotherapy after conserving surgery in low-risk early breast cancer patients","volume":"35","author":"Franco","year":"2018","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0220","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.clon.2019.05.021","volume":"31","author":"Gandhi","year":"2019","journal-title":"Clin Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2003.10.037","article-title":"T3 disease at presentation or pathologic involvment of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy","volume":"59","author":"Garg","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0230","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejca.2017.04.012","article-title":"Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: an analysis of the EORTC 10994\/BIG 1-00 study","volume":"79","author":"Gillon","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0235","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1200\/JCO.2005.06.232","article-title":"Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks","volume":"23","author":"Green","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0240","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","article-title":"Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS)","volume":"31","author":"Groen","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0245","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijrobp.2015.11.005","article-title":"Patterns of local-regional management following neoadjuvant chemotherapy in breast cancer: results from ACOSOG Z1071 (Alliance)","volume":"94","author":"Haffty","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0250","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijrobp.2019.04.038","article-title":"Impact of radiation on locoregional control in women with node-positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: results from ACOSOG Z1071 clinical trial","volume":"105","author":"Haffty","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0255","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.amjsurg.2016.07.018","article-title":"Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients","volume":"212","author":"Hage Chehade","year":"2016","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0260","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1016\/j.ijrobp.2011.08.015","article-title":"Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ","volume":"82","author":"Halasz","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0265","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.breast.2017.06.011","article-title":"Radiation therapy utilization and outcomes for older women with breast cancer: impact of molecular subtype and tumor grade","volume":"35","author":"Haque","year":"2017","journal-title":"Breast."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0270","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ijrobp.2013.08.026","article-title":"Hypofractionated radiation therapy for breast ductal carcinoma in situ","volume":"87","author":"Hathout","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0275","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0280","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.radonc.2016.08.027","article-title":"START Trial Management Group. 2016. Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: an analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation","volume":"121","author":"Haviland","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0285","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clbc.2018.02.006","article-title":"Omission of adjuvant radiotherapy in the elderly breast cancer patient: missed opportunity?","volume":"18","author":"Herskovic","year":"2018","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0290","series-title":"Breast In: AJCC Cancer Staging Manual","first-page":"589","author":"Hortobagyi","year":"2017"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0295","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.ejca.2012.05.023","article-title":"Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy","volume":"48","author":"Houssami","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0300","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1200\/JCO.2004.11.129","article-title":"Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy","volume":"22","author":"Huang","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0305","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2004.09.056","article-title":"Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy","volume":"62","author":"Huang","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0310","doi-asserted-by":"crossref","first-page":"39703","DOI":"10.18632\/oncotarget.14407","article-title":"Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0315","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0320","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.clbc.2016.10.005","article-title":"Hypofractionation is an acceptable alternative to conventional fractionation in the treatment of postlumpectomy ductal carcinoma in situ with radiotherapy","volume":"17","author":"Isfahanian","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0325","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.2013.52.2284","article-title":"Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States","volume":"32","author":"Jagsi","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0330","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamaoncol.2015.2590","article-title":"Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort","volume":"1","author":"Jagsi","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0335","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/SLA.0000000000001177","article-title":"Complications after mastectomy and immediate breast reconstruction for breast cancer: a claims-based analysis","volume":"263","author":"Jagsi","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0340","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000178162","article-title":"Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy","volume":"76","author":"Jiveliouk","year":"2009","journal-title":"Oncology."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0345","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1002\/cncr.28865","article-title":"Postmastectomy radiation therapy for T3N0: a SEER analysis","volume":"120","author":"Johnson","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0350","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2019.04.010","article-title":"ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer","volume":"137","author":"Kaidar-Person","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0355","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1245\/s10434-010-1335-2","article-title":"Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC\/Van Nuys Prognostic Index","volume":"18","author":"Kelley","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0360","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1245\/s10434-014-3494-z","article-title":"A systematic review of morbidity associated with autologous breast reconstruction before and after exposure to radiotherapy: are current practices ideal?","volume":"21","author":"Kelley","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0365","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10549-014-3025-4","article-title":"Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04)","volume":"146","author":"Kim","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0370","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10549-015-3505-1","article-title":"Does internal mammary node irradiation affect treatment outcome in clinical stage II\u2013III breast cancer patients receiving neoadjuvant chemotherapy?","volume":"152","author":"Kim","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0375","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.clon.2016.06.007","article-title":"It\u2019s PRIMETIME. Postoperative avoidance of radiotherapy: biomarker selection of women at very low risk of local recurrence","volume":"28","author":"Kirwan","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0380","doi-asserted-by":"crossref","first-page":"513e","DOI":"10.1097\/PRS.0b013e318262f059","article-title":"Current status of implant-based breast reconstruction in patients receiving postmastectomy radiation therapy","volume":"130","author":"Kronowitz","year":"2012","journal-title":"Plast. Reconstr. Surg."},{"issue":"July 26","key":"10.1016\/j.critrevonc.2020.102967_bib0385","article-title":"Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials","volume":"2019","author":"Krug","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0390","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0395","article-title":"Association of germline genetic testing results with locoregional and systemic therapy in patients with breast Cancer","volume":"6","author":"Kurian","year":"2020","journal-title":"JAMA Oncol. Feb"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0400","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijrobp.2014.07.026","article-title":"Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast","volume":"90","author":"Lalani","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2010.12.054","article-title":"Radiotherapy for stage II breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy","volume":"82","author":"Le Scodan","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0410","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canrad.2015.02.011","article-title":"Which node area should be irradiated after neoadjuvant chemotherapy in breast cancer?","volume":"19","author":"Lemanski","year":"2015","journal-title":"Cancer Radiother."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0415","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2018.12.030","article-title":"Ductal carcinoma in situ and intraoperative partial breast irradiation: who are the best candidates? Long-term outcome of a single institution series","volume":"133","author":"Leonardi","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0420","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.breast.2010.03.003","article-title":"Hypofractionated breast radiotherapy: financial and economic consequences","volume":"19","author":"Lievens","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0425","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1748-717X-9-14","article-title":"No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction","volume":"9","author":"Liljegren","year":"2014","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0430","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","article-title":"Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial","volume":"51","author":"Livi","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0435","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","article-title":"Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27","volume":"30","author":"Mamounas","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2020.102967_bib0440","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ijrobp.2018.08.048","article-title":"Randomized trial evaluating radiation following surgical excision for \u00ab\u202fgood risk\u202f\u00bb DCIS: 12-year report from NRG\/RTOG 9804","volume":"102","author":"McCormick","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0445","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0450","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ijrobp.2007.01.023","article-title":"Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy","volume":"68","author":"McGuire","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0455","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ejso.2013.03.002","article-title":"Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients","volume":"39","author":"Meattini","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0460","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2017.01.023","article-title":"Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: health-related quality of life final analysis from the Florence phase 3 trial","volume":"76","author":"Meattini","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0465","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1245\/s10434-013-3284-z","article-title":"A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy","volume":"21","author":"Momoh","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0470","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ijrobp.2008.12.014","article-title":"Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage","volume":"75","author":"Monteau","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"August 23 (4)","key":"10.1016\/j.critrevonc.2020.102967_bib0475","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.breast.2014.01.011","article-title":"Hypofractionated breast radiotherapy: FAQs (frequently asked questions) and facts","volume":"2014","author":"Montero","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0480","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.critrevonc.2019.04.016","article-title":"The Assisi Think Tank Meeting survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice","volume":"138","author":"Montero-Luis","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0485","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaoncol.2016.6948","article-title":"Association of radiotherapy boost for ductal carcinoma in situ with local control after whole-breast radiotherapy","volume":"3","author":"Moran","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0490","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2006.03.040","article-title":"The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy","volume":"66","author":"Motwani","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0495","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2010.06.027","article-title":"Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer","volume":"81","author":"Nagar","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0500","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.radonc.2015.01.001","article-title":"The role of boost and hypofractionation as adjuvant radiotherapy in patients with DCIS: a meta-analysis of observational studies","volume":"11","author":"Nilsson","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0505","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/bjc.2014.26","article-title":"Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II\u2013III breast cancer? A multicentre retrospective study (KROG 12-05)","volume":"110","author":"Noh","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"Suppl.1","key":"10.1016\/j.critrevonc.2020.102967_bib0510","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(17)30110-7","article-title":"Hypo- vs normofractionated radiation therapy of early stage breast cancer in the randomized DBCG HYPO trial","volume":"72","author":"Offersen","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0515","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijrobp.2017.06.2458","article-title":"Postmastectomy radiation in breast cancer patients with pathologically positive lymph nodes after neoadjuvant chemotherapy: usage rates and survival trends","volume":"99","author":"Ohri","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0520","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1200\/JCO.2013.50.5511","article-title":"Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy","volume":"31","author":"Olivotto","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0525","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1470-2045(06)70765-3","article-title":"Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the rare cancer network","volume":"7","author":"Omlin","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0530","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0535","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijrobp.2010.05.030","article-title":"Accelerated partial breast irradiation for pure ductal carcinoma in situ","volume":"81","author":"Park","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0540","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2013.05.008","article-title":"Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial","volume":"108","author":"Polg\u00e1r","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0545","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.brachy.2017.03.003","article-title":"Risk factors and state-of-the-art indications for boost irradiation in invasive breast carcinoma","volume":"16","author":"Polo","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0550","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1200\/JCO.2017.72.7388","article-title":"Breast reconstruction with postmastectomy radiation: choices and tradeoffs","volume":"35","author":"Poppe","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0555","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2006.12.045","article-title":"Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer","volume":"68","author":"P\u00f6tter","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0560","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijrobp.2013.02.031","article-title":"Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis","volume":"86","author":"Rakovitch","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0565","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-015-3464-6","article-title":"A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone","volume":"152","author":"Rakovitch","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0570","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.breast.2017.07.002","article-title":"Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy","volume":"7","author":"Rakovitch","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0575","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1200\/JCO.2016.67.8532","article-title":"Cost effectiveness of the oncotype dx dcis score for guiding treatment of patients with ductal carcinoma in situ","volume":"34","author":"Raldow","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0580","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2008.06.1954","article-title":"Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapy","volume":"72","author":"Rashtian","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0585","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.1997.15.3.963","article-title":"Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon","volume":"15","author":"Romestaing","year":"1997","journal-title":"France. J Clin Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0590","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/annonc\/mdw046","article-title":"The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a national cancer database (NCDB) analysis","volume":"27","author":"Rusthoven","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0595","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2015.65.1869","article-title":"Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: a population-based longitudinal cohort study","volume":"34","author":"Sagara","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0600","first-page":"297","article-title":"Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome","volume":"180","author":"Sataloff","year":"1995","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0605","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(18)30195-5","article-title":"Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial","volume":"19","author":"Sch\u00e4fer","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0610","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clbc.2012.04.006","article-title":"Clinical outcomes using accelerated partial breast irradiation in patients with ductal carcinoma in situ","volume":"12","author":"Shah","year":"2012","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0615","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/COC.0000000000000102","article-title":"Ductal carcinoma in situ of the breast: evaluating the role of radiation therapy in the management and attempts to identify low-risk patients","volume":"38","author":"Shah","year":"2015","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0620","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","article-title":"Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial","volume":"1","author":"Shaitelman","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0625","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijrobp.2013.09.021","article-title":"The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05)","volume":"88","author":"Shim","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0630","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jncimonographs\/lgq040","article-title":"Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California\/Van Nuys Prognostic Index","volume":"2010","author":"Silverstein","year":"2010","journal-title":"J Natl Cancer Inst Monogr."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0635","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1055\/s-2007-1022338","article-title":"Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy","volume":"54","author":"Sinn","year":"1994","journal-title":"Geburtshilfe"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0640","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0645","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0650","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study","volume":"33","author":"Solin","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0655","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0660","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1200\/JCO.2015.63.1010","article-title":"Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype","volume":"35","author":"Symmans","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0665","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1245\/s10434-016-5673-6","article-title":"Comparison of local recurrence after simple and skin-sparing mastectomy performed in patients with ductal carcinoma in situ","volume":"24","author":"Timbrell","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0670","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","article-title":"Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial","volume":"383","author":"Vaidya","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0675","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2019.07.001","article-title":"The 2017 Assisi Think Tank Meeting on rectal cancer: a positioning paper","volume":"142","author":"Valentini","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0680","doi-asserted-by":"crossref","first-page":"e899","DOI":"10.1016\/j.clbc.2018.02.009","article-title":"Trends and patterns of utilization of hypofractionated postmastectomy radiotherapy: a national cancer database analysis","volume":"18","author":"Venigalla","year":"2018","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0685","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0690","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0695","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised phase 3 equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0700","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1748-717X-7-177","article-title":"Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study","volume":"25","author":"Vidali","year":"2012","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0705","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cncr.25344","article-title":"Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ","volume":"117","author":"Wai","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0710","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.surge.2014.04.004","article-title":"Postmastectomy radiotherapy: indications and implications","volume":"12","author":"Walsh","year":"2014","journal-title":"Surgeon"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0715","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0720","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0725","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","article-title":"Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial","volume":"32","author":"W\u00e4rnberg","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0730","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0735","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2020.102967_bib0740","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2010.03.021","article-title":"Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ","volume":"95","author":"Williamson","year":"2010","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0745","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.ijrobp.2011.03.045","article-title":"Ductal carcinoma in situ--the influence of the radiotherapy boost on local control","volume":"82","author":"Wong","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0750","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/cncr.27717","article-title":"Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation","volume":"119","author":"Wright","year":"2013","journal-title":"Cancer"},{"issue":"1093","key":"10.1016\/j.critrevonc.2020.102967_bib0755","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170849","article-title":"Changes in radiotherapy fractionation - breast cancer","volume":"92","author":"Yarnold","year":"2019","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2010.08.035","article-title":"Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities","volume":"79","author":"Yarnold","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.102967_bib0765","first-page":"507","article-title":"Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?","volume":"53","author":"Yerushalmi","year":"2006","journal-title":"Neoplasma"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820301050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820301050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:34:10Z","timestamp":1760902450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842820301050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":153,"alternative-id":["S1040842820301050"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102967","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2018 assisi think tank meeting on breast cancer: International expert panel white paper","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102967"}}